Leveraging new technology in flow cytometry offers oncology labs the opportunity to expand their capabilities beyond diagnosis, giving cancer patients and their physicians precise results ...

The pilot will run for six months. The hope is that the technology will allow early diagnosis, which in turn will improve cancer outcomes, as treatment will be possible at the earliest stage ...